KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 127 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $80,000 | -10.1% | 23,650 | 0.0% | 0.01% | -21.4% |
| Q2 2018 | $89,000 | -8.2% | 23,650 | 0.0% | 0.01% | -6.7% |
| Q1 2018 | $97,000 | -11.8% | 23,650 | 0.0% | 0.02% | -11.8% |
| Q4 2017 | $110,000 | -34.5% | 23,650 | 0.0% | 0.02% | -43.3% |
| Q3 2017 | $168,000 | -1.8% | 23,650 | 0.0% | 0.03% | 0.0% |
| Q2 2017 | $171,000 | +17.1% | 23,650 | 0.0% | 0.03% | +15.4% |
| Q1 2017 | $146,000 | -2.0% | 23,650 | -7.3% | 0.03% | -13.3% |
| Q4 2016 | $149,000 | +10.4% | 25,500 | 0.0% | 0.03% | -3.2% |
| Q3 2016 | $135,000 | – | 25,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |